Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

Clinical relevance of combined FSH and AMH observations in infertile women.

Gleicher N, Kim A, Kushnir V, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH.

J Clin Endocrinol Metab. 2013 May;98(5):2136-45. doi: 10.1210/jc.2013-1051. Epub 2013 Mar 26.

PMID:
23533225
2.

Toward a better understanding of functional ovarian reserve: AMH (AMHo) and FSH (FSHo) hormone ratios per retrieved oocyte.

Gleicher N, Kim A, Weghofer A, Barad DH.

J Clin Endocrinol Metab. 2012 Mar;97(3):995-1004. doi: 10.1210/jc.2011-2403. Epub 2011 Dec 14.

PMID:
22170712
3.

Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.

Schufreider A, McQueen DB, Lee SM, Allon R, Uhler ML, Davie J, Feinberg EC.

Hum Reprod. 2015 Nov;30(11):2686-92. doi: 10.1093/humrep/dev220. Epub 2015 Sep 6.

PMID:
26345686
4.

Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene.

Gleicher N, Kim A, Weghofer A, Barad DH.

Reprod Biol Endocrinol. 2012 Sep 10;10:77. doi: 10.1186/1477-7827-10-77.

5.

Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility.

Gleicher N, Weghofer A, Barad DH.

Reprod Biol Endocrinol. 2010 Jun 17;8:64. doi: 10.1186/1477-7827-8-64.

6.

Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.

Lukaszuk K, Kunicki M, Liss J, Lukaszuk M, Jakiel G.

Eur J Obstet Gynecol Reprod Biol. 2013 Jun;168(2):173-7. doi: 10.1016/j.ejogrb.2013.01.013. Epub 2013 Feb 26.

PMID:
23485092
7.

Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR).

Gleicher N, Kim A, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH.

J Assist Reprod Genet. 2013 Jan;30(1):49-62. doi: 10.1007/s10815-012-9890-z. Epub 2012 Dec 5.

8.

Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle.

Lin PY, Huang FJ, Kung FT, Chiang HJ, Lin YJ, Lin YC, Lan KC.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6245-53. eCollection 2014.

9.

A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone.

Gleicher N, Weghofer A, Barad DH.

Fertil Steril. 2009 May;91(5):1700-6. doi: 10.1016/j.fertnstert.2008.01.098. Epub 2008 Apr 2.

PMID:
18384775
10.

Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test?

Gleicher N, Weghofer A, Oktay K, Barad DH.

Acta Obstet Gynecol Scand. 2009;88(9):1024-30. doi: 10.1080/00016340903171058.

PMID:
19642041
11.

[Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].

Grzegorczyk-Martin V, Khrouf M, Bringer-Deutsch S, Mayenga JM, Kulski O, Cohen-Bacrie P, Benaim JL, Belaisch-Allart J.

Gynecol Obstet Fertil. 2012 Jul-Aug;40(7-8):411-8. doi: 10.1016/j.gyobfe.2012.02.001. Epub 2012 Apr 20. French.

PMID:
22521986
12.

Effect of inter-cycle interval on oocyte production in humans in the presence of the weak androgen DHEA and follicle stimulating hormone: a case-control study.

Barad DH, Kushnir VA, Lee HJ, Lazzaroni E, Gleicher N.

Reprod Biol Endocrinol. 2014 Jul 21;12:68. doi: 10.1186/1477-7827-12-68.

13.

The impact in older women of ovarian FMR1 genotypes and sub-genotypes on ovarian reserve.

Gleicher N, Weghofer A, Kim A, Barad DH.

PLoS One. 2012;7(3):e33638. doi: 10.1371/journal.pone.0033638. Epub 2012 Mar 16.

14.

Utility of age-specific serum anti-Müllerian hormone concentrations.

Barad DH, Weghofer A, Gleicher N.

Reprod Biomed Online. 2011 Mar;22(3):284-91. doi: 10.1016/j.rbmo.2010.12.002. Epub 2010 Dec 13.

PMID:
21269880
15.

Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.

Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R.

Fertil Steril. 2013 May;99(6):1644-53. doi: 10.1016/j.fertnstert.2012.12.048. Epub 2013 Feb 5.

16.

How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields.

Gleicher N, Darmon SK, Kushnir VA, Weghofer A, Wang Q, Zhang L, Albertini DF, Barad DH.

Endocrine. 2016 Nov;54(2):476-483. Epub 2016 Aug 10.

PMID:
27510172
17.

Age at menarche: a predictor of diminished ovarian function?

Weghofer A, Kim A, Barad DH, Gleicher N.

Fertil Steril. 2013 Oct;100(4):1039-43. doi: 10.1016/j.fertnstert.2013.05.042. Epub 2013 Jun 27.

PMID:
23809497
18.

The relationship between the number of CGG repeats and serum level of anti-Müllerian hormone in women without FMR1 premutation.

Choe SA, Kim KC, Lee JY, Kim CH, Hwang D, Jee BC.

Eur J Obstet Gynecol Reprod Biol. 2013 Jul;169(2):275-8. doi: 10.1016/j.ejogrb.2013.05.002. Epub 2013 May 31.

PMID:
23731704
19.

The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation.

Weghofer A, Kim A, Barad DH, Gleicher N.

Hum Reprod. 2012 Nov;27(11):3287-93. doi: 10.1093/humrep/des265. Epub 2012 Jul 18.

PMID:
22811313
20.

Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.

Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.

Fertil Steril. 2009 Nov;92(5):1586-93. doi: 10.1016/j.fertnstert.2008.08.127. Epub 2008 Oct 18.

PMID:
18930213

Supplemental Content

Support Center